Clinical Features and Co-Infections in Invasive Pulmonary Aspergillosis in Elderly Patients

References

• Ledoux P, Guffroy B, Nivoix Y, et al. Invasive Pulmonary aspergillosis. Semin Respir Crit Care Med. 2020;41(1):80–98. doi:10.1055/s-0039-340199032000286
   PubMed Web of Science ®Google Scholar
• Kousha M, Tadi R, Soubani A. Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011;20(121):156–174. doi:10.1183/09059180.0000101121881144
   PubMedGoogle Scholar
• Perfect J, Cox G, Lee J, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis. 2001;33(11):1824–1833. doi:10.1086/32390011692293
   PubMed Web of Science ®Google Scholar
• Daniel J, Chun H. Mechanisms of dysfunction in senescent pulmonary endothelium. J Gerontol a Biol Sci Med Sci. 2012;67(3):236–241. doi:10.1093/gerona/glr24822396472
   PubMed Web of Science ®Google Scholar
• Webster R. Immunity to influenza in the elderly. Vaccine. 2000;18(16):1686–1689. doi:10.1016/s0264-410x(99)00507-110689149
   PubMed Web of Science ®Google Scholar
• Peng L, Xu Z, Huo Z, et al. New insights into the clinical characteristics and prognostic factors of pulmonary fungal infections from a retrospective study in Southwestern China. Infect Drug Resist. 2018;11:307–315. doi:10.2147/IDR.S15703029551904
   PubMed Web of Science ®Google Scholar
• Lao M, Zhan Z, Su F, et al. Invasive mycoses in patients with connective tissue disease from Southern China: clinical features and associated factors. Arthritis Res Ther. 2019;21(1):71. doi:10.1186/s13075-019-1851-930867045
   PubMed Web of Science ®Google Scholar
• Gong Y, Li C, Wang C, et al. Epidemiology and mortality-associated factors of invasive fungal disease in elderly patients: a 20-year retrospective study from Southern China. Infect Drug Resist. 2020;13:711–723. doi:10.2147/IDR.S24218732184633
   PubMed Web of Science ®Google Scholar
• Pauw B, Walsh T, Donnelly J, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813–1821. doi:10.1086/58866018462102
   PubMed Web of Science ®Google Scholar
• Magiorakos A, Srinivasan A, Carey R, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Germán P, Fernández-Urrusuno R, María J, et al. Long-term impact of an educational antimicrobial stewardship programme in primary care on infections caused by extended-spectrum β-lactamase-producing Escherichia coli in the community: an interrupted time-series analysis. Lancet Infect Dis. 2020;20(2):199–207. doi:10.1016/S1473-3099(19)30573-031767423
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Common terminology criteria for adverse events version 3.0. 2003 Available from: https://ctepcancergov/protocoldevelopment/electronic_applications/docs/ctcaev3pdf. Accessed 928, 2020.
   Google Scholar
• Zhang Z, Shen T. Diagnosis and Treatment of Blood Diseases. 3nd ed. Beijing, Chinese: Science Press; 2007.
   Google Scholar
• Dib R, Khalil M, Fares J, et al. Invasive pulmonary aspergillosis: comparative analysis in cancer patients with underlying haematologic malignancies versus solid tumours. J Hosp Infect. 2020;104(3):358–364. doi:10.1016/j.jhin.2019.09.02031585141
   PubMed Web of Science ®Google Scholar
• Stevens D, Melikian G. Aspergillosis in the ‘nonimmunocompromised’ host. Immunol Invest. 2011;40(7–8):751–766. doi:10.3109/08820139.2011.61430721985304
   PubMed Web of Science ®Google Scholar
• Patterson T, Thompson G 3rd, Denning D, et al. Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1–e60. doi:10.1093/cid/ciw32627365388
   PubMed Web of Science ®Google Scholar
• Kosmidis C, Denning D. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015;70(3):270–277. doi:10.1136/thoraxjnl-2014-20629125354514
   PubMed Web of Science ®Google Scholar
• Bartolome C, Claudia C, Jose M, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa02132214999112
   PubMed Web of Science ®Google Scholar
• Emanuele A, Shilpa B, David W, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776–786. doi:10.1016/S0140-6736(16)30175-127423262
   PubMed Web of Science ®Google Scholar
• Amundson D, Djurkovic S, Matwiyoff G. The obesity paradox. Crit Care Clin. 2010;26(4):583–596. doi:10.1016/j.ccc.2010.06.00420970043
   PubMed Web of Science ®Google Scholar
• Zafrir B, Adir Y, Shehadeh W, et al. The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the “obesity paradox”. Respir Med. 2013;107(1):139–146. doi:10.1016/j.rmed.2012.10.01923199841
   PubMed Web of Science ®Google Scholar
• Carnethon M, De Chavez P, Biggs M, et al. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308(6):581–590. doi:10.1001/jama.2012.928222871870
   PubMed Web of Science ®Google Scholar
• Bottai M, Pistelli F, Di Pede F, et al. Longitudinal changes of body mass index, spirometry and diffusion in a general population. Eur Respir J. 2002;20(3):665–673. doi:10.1183/09031936.02.0128200112358345
   PubMed Web of Science ®Google Scholar
• Franssen F, O’Donnell D, Goossens G, et al. Obesity and the lung: 5. Obesity and COPD. Thorax. 2008;63(12):1110–1117. doi:10.1136/thx.2007.08682719020276
   PubMed Web of Science ®Google Scholar
• WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163. doi:10.1016/S0140-6736(03)15268-314726171
   PubMed Web of Science ®Google Scholar
• Kim S, Yoon Y, Kim M, et al. Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections. Clin Microbiol Infect. 2013;19(1):62–68. doi:10.1111/j.1469-0691.2012.03906.x22651822
   PubMed Web of Science ®Google Scholar
• Abi‐Said D, Anaissie E, Uzun O, et al. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis. 1997;24(6):1122–1128. doi:10.1086/5136639195068
   PubMed Web of Science ®Google Scholar
• Dyess D, Garrison R, Fry D. Candida sepsis. Implications of polymicrobial blood-borne infection. Arch Surg. 1985;120(3):345–348. doi:10.1001/archsurg.1985.013902700830143970669
   PubMedGoogle Scholar
• Leclair L, Hogan D. Mixed bacterial-fungal infections in the CF respiratory tract. Med Mycol. 2010;48(Suppl 1):S125–S132. doi:10.3109/13693786.2010.52152221067324
   PubMed Web of Science ®Google Scholar
• Reece E, Segurado R, Jackson A, et al. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis. BMC Pulm Med. 2017;17(1):70. doi:10.1186/s12890-017-0416-428431569
   PubMed Web of Science ®Google Scholar
• Ho J, Tambyah P, Paterson D. Multiresistant gram-negative infections: a global perspective. Curr Opin Infect Dis. 2010;23(6):546–553. doi:10.1097/QCO.0b013e32833f0d3e20802331
   PubMed Web of Science ®Google Scholar
• Barberán J, García-Pérez FJ, Villena V, et al. Development of Aspergillosis in a cohort of non-neutropenic, non-transplant patients colonised by Aspergillus spp. BMC Infect Dis. 2017;17:34. doi:10.1186/s12879-016-2143-528056830
   PubMed Web of Science ®Google Scholar
• Delsuc C, Cottereau A, Frealle E, et al. Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study. Crit Care. 2015;19:421. doi:10.1186/s13054-015-1140-126631029
   PubMed Web of Science ®Google Scholar
• Bueno V, Sant’Anna O, Lord J. Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease. Age (Dordr). 2014;36(6):9729. doi:10.1007/s11357-014-9729-x25399072
   PubMedGoogle Scholar
• Sharma R, Kapila R, Haq M, et al. Age-associated aberrations in mouse cellular and humoral immune responses. Aging Clin Exp Res. 2014;26(4):353–362. doi:10.1007/s40520-013-0190-y24343854
   PubMed Web of Science ®Google Scholar
• Wüthrich M, George SD Jr, Bruce K. Adaptive immunity to fungi. Annu Rev Immunol. 2012;30:115–148. doi:10.1146/annurev-immunol-020711-07495822224780
   PubMed Web of Science ®Google Scholar
• Moro-García M, Alonso-Arias R, López-Larrea C. Molecular mechanisms involved in the aging of the T-cell immune response. Curr Genomics. 2012;13(8):589–602. doi:10.2174/13892021280375974923730199
   PubMed Web of Science ®Google Scholar
• Chou J, Effros R. T cell replicative senescence in human aging. Curr Pharm Des. 2013;19(9):1680–1698. doi:10.2174/13816121380521971123061726
   PubMed Web of Science ®Google Scholar
• Renata K, Elżbieta M, Wojciech K. The etiology of lower respiratory tract infections in people with diabetes. Pneumonol Alergol Pol. 2015;83(5):401–408. doi:10.5603/PiAP.2015.006526379004
   PubMedGoogle Scholar
• Donnelly J, Sharon C, Carol K, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2019:ciz1008. doi:10.1093/cid/ciz1008
   Web of Science ®Google Scholar